These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22137920)

  • 21. Remission by imaging in rheumatoid arthritis: should this be the ultimate goal?
    van der Heijde D
    Ann Rheum Dis; 2012 Apr; 71 Suppl 2():i89-92. PubMed ID: 22460147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-driven outcomes in rheumatoid arthritis.
    Wells GA
    J Rheumatol Suppl; 2009 Jun; 82():33-8. PubMed ID: 19509328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does clinical remission lead to normalization of EQ-5D in patients with rheumatoid arthritis and is selection of remission criteria important?
    Linde L; Sørensen J; Østergaard M; Hørslev-Petersen K; Hetland ML
    J Rheumatol; 2010 Feb; 37(2):285-90. PubMed ID: 20080905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritis.
    Wolfe F; Rasker JJ; Boers M; Wells GA; Michaud K
    Arthritis Rheum; 2007 Aug; 57(6):935-42. PubMed ID: 17665487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985.
    Pincus T; Sokka T; Kautiainen H
    Arthritis Rheum; 2005 Apr; 52(4):1009-19. PubMed ID: 15818706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short-term outcome after anti-tumor necrosis factor-alpha therapy in rheumatoid arthritis: do we need to revise our assessment criteria?
    El Miedany Y; Youssef SS; El Gaafary M
    J Rheumatol; 2006 Mar; 33(3):490-7. PubMed ID: 16511918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous indices of core data set measures in rheumatoid arthritis clinical trials: lower responses to placebo than seen with categorical responses with the American College of Rheumatology 20% criteria.
    Pincus T; Amara I; Koch GG
    Arthritis Rheum; 2005 Apr; 52(4):1031-6. PubMed ID: 15818698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unresolved issues in identifying and overcoming inadequate response in rheumatoid arthritis: weighing the evidence.
    Cohen SB; Cohen MD; Cush JJ; Fleischmann RM; Mease PJ; Schiff MH; Simon LS; Weaver AL
    J Rheumatol Suppl; 2008 Feb; 81():4-30; quiz 31-4. PubMed ID: 19193621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing remission in clinical practice.
    Mierau M; Schoels M; Gonda G; Fuchs J; Aletaha D; Smolen JS
    Rheumatology (Oxford); 2007 Jun; 46(6):975-9. PubMed ID: 17341506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early rheumatoid arthritis -- is there a window of opportunity?
    Cush JJ
    J Rheumatol Suppl; 2007 Nov; 80():1-7. PubMed ID: 17985417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A proposed 30-45 minute 4 page standard protocol to evaluate rheumatoid arthritis (SPERA) that includes measures of inflammatory activity, joint damage, and longterm outcomes.
    Pincus T; Brooks RH; Callahan LF
    J Rheumatol; 1999 Feb; 26(2):473-80. PubMed ID: 9972990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The new ACR/EULAR remission criteria: rationale for developing new criteria for remission.
    Bykerk VP; Massarotti EM
    Rheumatology (Oxford); 2012 Dec; 51 Suppl 6():vi16-20. PubMed ID: 23221582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis.
    Pincus T
    Bull NYU Hosp Jt Dis; 2008; 66(3):216-23. PubMed ID: 18937635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High dose chemotherapy and hematopoietic stem cell transplantation: a study of treatment preference in patients with rheumatoid arthritis and rheumatologists.
    Verburg RJ; Mahabali SD; Stiggelbout AM; Sont JK; van Laar JM
    J Rheumatol; 2002 Aug; 29(8):1653-8. PubMed ID: 12180724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achieving tight control in rheumatoid arthritis.
    van Hulst LT; Hulscher ME; van Riel PL
    Rheumatology (Oxford); 2011 Oct; 50(10):1729-31. PubMed ID: 21933791
    [No Abstract]   [Full Text] [Related]  

  • 38. Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials.
    Strand V; Singh JA
    Am J Manag Care; 2007 Dec; 13 Suppl 9():S237-51. PubMed ID: 18095787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Imaging in rheumatoid arthritis.
    Tan YK; Conaghan PG
    Best Pract Res Clin Rheumatol; 2011 Aug; 25(4):569-84. PubMed ID: 22137925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppressing Inflammation in Rheumatoid Arthritis: Does Patient Global Assessment Blur the Target? A Practice-Based Call for a Paradigm Change.
    Ferreira RJO; Duarte C; Ndosi M; de Wit M; Gossec L; da Silva JAP
    Arthritis Care Res (Hoboken); 2018 Mar; 70(3):369-378. PubMed ID: 28544615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.